During the past decade, Central NII tuberkuleza RAMN conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Central NII tuberkuleza RAMN" are "Idiopathic Pulmonary Fibrosis" (2 trials). Many other conditions were trialed in "Central NII tuberkuleza RAMN" in a lesser frequency.

Most popular intervention types in "Central NII tuberkuleza RAMN" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "PRM-151 (Zinpentraxin Alfa)" (1 trials) and "Pirfenidone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central NII tuberkuleza RAMN" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Central NII tuberkuleza RAMN". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Central NII tuberkuleza RAMN, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Central NII tuberkuleza RAMN, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".